MIRIAM REED: Open Payments
NPI 1871104703 · MONTROSE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 10 payments from 9 companies in 2025. Trend: 2023 $904 · 2024 $101 · 2025 $360
Food & beverage: $260Education: $100
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 1 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Grifols USA, LLC | 1 | $25 |
| Insmed, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Pulmonx Corporation | 1 | $19 |
Products named: DUPIXENT, WINREVAIR, Prolastin-C Liquid, Arikayce, NUCALA, CHARTIS CATHETER, BREZTRI, TEZSPIRE.
Industry payments across CO — which companies pay providers there.
